Brief: EmendoBio Says Acquired By AnGes
15/12/2020 13:43
Dec 15 (Reuters) - EmendoBio Inc:
* EMENDOBIO GENE EDITING COMPANY ACQUIRED BY ANGES, INC.
Source text for Eikon: ID:nBw5KwzFWa
Further company coverage: 4563.T
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AnGes
See all newsTable: Anges -Q1 group results
Brief: Vasomune Therapeutics, Inc., And Anges, Inc., Announce Us FDA Clearance Of Investigational New Drug (Ind) Application For Pegevongitide (Av-001) Treatment In Resuscitation Of Severely Burned Patients
Table: Anges -2025 parent results
Table: Anges -2025 group results
Brief: Anges & Vasomune Therapeutics Enter Agreement For AV-001